Quotes 5-day view Delayed Nasdaq
1 224 941
1 750 048
Estimated financial data (e) (USD)
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Athersys, Inc. is a biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem (invimestrocel) cell therapy, which is an allogeneic stem cell product candidate, is its lead platform product. The MultiStem cell therapy includes the treatment of critical care indications, neurological conditions, inflammatory and immune disorders, certain pulmonary conditions,...
Ratings of Athersys, Inc.
All news about ATHERSYS, INC.
01/21 Health Care Stocks Decline Pre-Bell Friday
01/21 ATHERSYS, INC / NEW : Change in Directors or Principal Officers (form 8-K)
01/21 Athersys Appoints Chief Executive Officer
01/20 Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive ..
01/20 Athersys, Inc. Appoints Daniel A. Camardo to the Board of Directors, Effective February..
01/20 Athersys, Inc. Appoints Daniel A. Camardo as Chief Executive Officer, Effective Februar..
2021 ATHERSYS, INC / NEW : Change in Directors or Principal Officers (form 8-K)
2021 Report of Placebo-Controlled Clinical Trial Evaluating MultiStem« Cell Therapy for Acut..
2021 Athersys, Inc. Announces Manuscript Reporting Data from the Company?s Must-ARDS Clinica..
2021 BofA Securities Downgrades Athersys to Neutral From Buy; Price Target is $1.25
2021 ATHERSYS : REPORTS THIRD QUARTER 2021 RESULTS AND PROVIDES CORPORATE UPDATE - Form 8-K
2021 Earnings Flash (ATHX) ATHERSYS Reports Q3 Revenue $4.8M
2021 Athersys, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2021
2021 Athersys Reports Third Quarter 2021 Results and Provides Corporate Update
2021 Athersys Reports Updates on Timing for Japan ARDS and Stroke Programs From Healios K.K.
News in other languages on ATHERSYS, INC.
Analyst Recommendations on ATHERSYS, INC.
Technical analysis trends ATHERSYS, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target